Auditor Michael Gillespie & Associates agrees with Item 4.02 disclosures
Michael Gillespie & Associates, PLLC has confirmed agreement with Goldenwell Biotech's statements regarding auditor changes filed on May 26, 2026. This auditor acknowledgment letter is a standard regulatory requirement when companies change accounting firms.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day